Human genetic evidence supports fibroblast growth factor 21 as a novel therapeutic target for gout

被引:0
|
作者
Zhao, Sizheng Steven [1 ]
Cuthbertson, Daniel J. [2 ,3 ]
Alam, Uazman [3 ,4 ,5 ,6 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr, Sch Biol Sci,Ctr Musculoskeletal Res,Div Musculosk, Oxford Rd, Manchester M13 9LJ, England
[2] Univ Liverpool, Dept Cardiovasc & Metab Med, Liverpool, England
[3] Liverpool Univ Hosp NHS Fdn Trust, Dept Med, Liverpool, England
[4] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Dept Cardiovasc & Metab Med, Liverpool, England
[5] Univ Liverpool, Pain Res Inst, Liverpool, England
[6] Staffordshire Univ, Ctr Biomech & Rehabil Technol, Stoke On Trent, England
关键词
D O I
10.1093/rheumatology/keae210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:e288 / e289
页数:2
相关论文
共 50 条
  • [1] The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target
    Liu, Wen-Yue
    Huang, Sha
    Shi, Ke-Qing
    Zhao, Chen-Chen
    Chen, Li-Li
    Braddock, Martin
    Chen, Yong-Ping
    Feng, Wen-Ke
    Zheng, Ming-Hua
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (11) : 1305 - 1313
  • [2] Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus
    So, Wing Yan
    Leung, Po Sing
    [J]. MEDICINAL RESEARCH REVIEWS, 2016, 36 (04) : 672 - 704
  • [3] Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases
    Cheung, Bernard M. Y.
    Deng, H. B.
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (06) : 659 - 666
  • [4] Fibroblast Growth Factor 21 (FGF21) in NAFLD: From a Biomarker to a Therapeutic Target.
    Gallego-Duran, Rocio
    Martin-Bermudo, Francisco
    Ampuero, Javier
    Pastor-Ramirez, Helena
    Montero-Vallejo, Rocio
    Alvarez-Amor, Leticia
    Gil-Gomez, Antonio
    de los Angel Rojas, Maria
    Maya, Douglas
    Andreola, Fausto
    Jalan, Rajiv
    Romero-Gomez, Manuel
    [J]. HEPATOLOGY, 2018, 68 : 1014A - 1014A
  • [5] Fibroblast growth factor receptor 2 as a novel therapeutic target for cancer cell growth and angiogenesis in human pancreatic cancer
    Ishiwata, Toshiyuki
    Matsuda, Yoko
    Kawahara, Kiyoko
    Yamamoto, Tetsushi
    Teduka, Kiyoshi
    Suzuki, Taeko
    Peng, Wei-Xia
    Korc, Murray
    Naito, Zenya
    [J]. CANCER RESEARCH, 2011, 71
  • [6] Genetic Evidence Supporting Fibroblast Growth Factor 21 Signalling as a Pharmacological Target for Cardiometabolic Outcomes and Alzheimer's Disease
    Larsson, Susanna C.
    Gill, Dipender
    [J]. NUTRIENTS, 2021, 13 (05)
  • [7] Fibroblast growth factor receptor 2 as a novel therapeutic target for colorectal cancer cell growth
    Zenya, Naito
    Matsuda, Yoko
    Peng, Wei-Xia
    Yamahatsu, Kazuya
    Ueda, Junji
    Kawamoto, Yoko
    Teduka, Kiyoshi
    Seya, Tomoko
    Ohaki, Yoshiharu
    Ishiwata, Toshiyuki
    [J]. CANCER RESEARCH, 2011, 71
  • [8] Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease
    Raptis, Dimitrios
    Mantzoros, Christos S.
    Polyzos, Stergios A.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 77 - 96
  • [9] Fibroblast growth factor receptors 2 is a novel therapeutic target in esophagogastric junction adenocarcinoma
    Tokunaga, Ryuma
    Imamura, Yu
    Nakamura, Kenichi
    Ishimoto, Takatsugu
    Iwagami, Shiro
    Kurashige, Junji
    Izumi, Daisuke
    Kosumi, Keisuke
    Higaehi, Takaaki
    Taki, Katsunobu
    Hiyoshi, Yukiharu
    Baba, Yoehifumi
    Sakamoto, Yasuo
    Miyamoto, Yuji
    Yoshida, Naoya
    Hiroshi, Saeki
    Oki, Eiji
    Maehara, Yoshihiko
    Baba, Hideo
    [J]. CANCER RESEARCH, 2015, 75
  • [10] The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis
    Ronca, Roberto
    Giacomini, Arianna
    Rusnati, Marco
    Presta, Marco
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (10) : 1361 - 1377